Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1976-11-29
1978-11-07
Killos, Paul J.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
560 75, C07L 6976
Patent
active
041247248
ABSTRACT:
Novel crystalline products of manufacture are represented by the formula: ##STR1## wherein R.sub.1 and R.sub.2 are selected from the group consisting of hydroxyl and the caffeoyl group, with the limitation that only one of R.sub.1 and R.sub.2 can be hydroxyl, and the pharmaceutically acceptable salts of the indicated compounds. The compounds are useful as anti-venom agents for hemolytic snake venoms. Pharmaceutical preparations containing the above compounds, or the compound commonly known as caffeic acid wherein both R.sub.1 and R.sub.2 are hydroxyl, are provided for treatment of snakebite victims, as well as the method of using those preparations in such treatment.
REFERENCES:
patent: 2863909 (1958-12-01), Panizzi et al.
patent: 2918477 (1959-12-01), Alberti
patent: 3068148 (1962-12-01), Freedmen et al.
LandOfFree
Crystalline caffeic acid derivatives and compositions and method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystalline caffeic acid derivatives and compositions and method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline caffeic acid derivatives and compositions and method will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2234101